Carb Choice (AMY1 gene)
Your investment: $299
- Genetic testing kit and lab report: valued at $299
CarbChoice may offer you support for managing how your body processes starchy carbohydrates.
Fitgenes has provided genetic test reports from Australia since 2009, and is a world leader in developing genetic profile reports that provide dietary, lifestyle and exercise interventions based on the role of the AMY1 gene CNV in starchy carbohydrate metabolism.
Scientific studies have shown that variations in the human salivary amylase gene (AMY1) differ based on populations which have traditionally eaten high starch diets, compared to those who have traditionally eaten low starch diets (Perry et al. 2007). Copy number variations within the AMY1 gene impact salivary amylase activity (Yang et al. 2015; Santos et al. 2012), which influences how well the body breaks down and processes starch. Copy number variations and amylase activity can also impact the oral perception of starch leading to nutritional differences (Mandel et al. 2010).
Simply, some people can process starchy carbohydrates better than others, and this can impact their nutrition, dietary choices and health.
Amylase activity, and the ability to process starch, has been demonstrated to have impact on BMI (Bonnefond et al. 2017) and hence AMY1 copy number can impact on the related issues of BMI, obesity and weight management (Falchi et al. 2014; Mejía-Benítez et al. 2015; Viljakainen et al., 2015; Marcovecchio et al. 2016). Low amylase individuals may even be at greater risk of insulin resistance and diabetes if they maintain a high starch diet (Mandel and Breslin 2012).
The unique CarbChoice profile report contains:
- an easy to understand visual classification of the ability for starchy carbohydrate metabolism.
- data on typical carbohydrate content of many common foods.
- contains menu suggestion and meal plans.
- suggests potential exercise interventions (if required) to upregulate amylase activity